TPM3 and neoplasm: Neurotrophins, protein growth factors that activate RTKs of the tropomyosin receptor kinase (Trk) family, are known to be critically involved in regulating neuronal development and have also been increasingly implicated in tumor progression and resistance to treatment in several types of cancer, including those of possible neural origin [3,4,5].